CureApp North America careers

Our approach to reaching the goal is centered around Digital Therapeutics (DTx). DTx is a new field of medicine designed to approach the root cause of health conditions using mobile applications. Our method does so by modifying how users understand and think about their conditions (cognitive change) and by changing their lifestyle gradually (behavioral change) to treat the conditions.

CureApp is the leading company in the DTx field in Japan with the first and only DTx regulatory and reimbursement approvals*. Our pipeline includes nicotine addiction, hypertension, NASH liver disease, alcoholism, cancer treatment, and respiratory/cardiovascular conditions. With our successful market entrance in Japan, we are planning to expand our business to the U.S. market.

Challenges for us to enter the market include cultural and linguistic gaps. Because the treatment approaches cognition and behavior through educational contents and virtual counseling sessions, the contents of the application need